---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-001940"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T08:04:42.583012+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# VolitionRx shareholders approve share issuance to Lind Global and reverse stock split authorization

## Summary
- Proposal 1 (issuance >20% to Lind Global): 44.15M for, 14.10M against, 1.11M abstain, 21.15M broker non-votes approved.
- Proposal 2 (reverse split authorization): 62.84M for, 16.45M against, 1.22M abstain; board may choose ratio 1:5 to 1:20.
- Record date Feb 9, 2026: 135.57M shares outstanding; 80.51M shares present at special meeting on March 31, 2026.
- No other matters were presented for stockholder action at the special meeting.

## SEC filing metadata
- accession: 0001477932-26-001940
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/0001477932-26-001940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-001940
- JSON: https://secwatch.observer/filing/0001477932-26-001940.json
- Plain text: https://secwatch.observer/filing/0001477932-26-001940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.